GHK-Cu Pen 50 mg

50mg99,00 € incl. VAT

GHK-Cu Pen 50 mg: pre-filled pen with GHK-Cu (copper tripeptide) as a ready-to-use solution, 50 mg in a 2 mL cartridge (25 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.

Pre-order

Shipping from 11,93 € · Free EU shipping over 200 €

📋 View the Certificate of Analysis information

SKU: GHKCU-50MG-PEN-KIT Category:

Product specifications

Quantity50mg
Unit1 pre-filled pen
Purity data>99.8% (batch XD-CU50-PO06)
FormatPre-mixed pen (solution in cartridge)
Volume2 mL solution
Concentration25 mg/mL
Storage2–8 °C, protected from light
Source lotXD-CU50-PO06, tested by Liquilabs

Description

Research use only. Sold for laboratory research. Not a medicine, and not for human or veterinary use.

Pre-order

This pen is being prepared for its first production run. Orders placed now are reserved and ship as soon as stock arrives; you will get an email with tracking the day it leaves.

What is GHK-Cu?

GHK-Cu is a naturally occurring complex of the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion, first isolated from human plasma by Loren Pickart in 1973. It is found in plasma, saliva and urine, and its plasma level falls with age, from about 200 ng/ml at age 20 to about 80 ng/ml by age 60. The solution has a characteristic blue colour from the copper.

What the research shows

  • Collagen and skin matrix. In fibroblast cultures GHK-Cu increases the synthesis of collagen, elastin and glycosaminoglycans (Maquart et al., 1988, and later work).
  • Wound healing. In animal models it speeds wound closure, increases blood-vessel formation and raises antioxidant enzyme levels in the wound.
  • Skin appearance. Small controlled studies of topical GHK-Cu creams reported improved skin density and firmness and fewer fine lines over 8 to 12 weeks.
  • Hair. Copper-peptide analogues enlarged hair follicles in animal studies.
  • Gene expression. Genomic analyses suggest GHK shifts the expression of a large number of human genes, many of them involved in repair and antioxidant defence (Pickart and Margolina).
  • Anti-inflammatory activity. It lowers inflammatory cytokines such as TNF-alpha and IL-6 in cell and animal models.

Side effects reported in studies

Topical use is well tolerated in published studies. Injected GHK-Cu has not been through controlled human trials; stinging at the injection site is the effect most often described.

Doses reported in published studies

There is no established human dose for injected GHK-Cu. Human data come from topical formulations; animal wound-healing studies use local or systemic doses scaled to body weight.

This section summarises the doses used in the published literature. It is not a recommendation.

About the pre-mixed pen format

A pre-mixed pen holds the peptide already reconstituted inside a sealed cartridge, so there is no vial to open, no solvent to measure and no transfer step. The solution stays in a closed system from filling to use, and the dial delivers the same volume on every click. Each pen is filled from a lot of lyophilised substance that has already been through independent testing; the lot number is shown on this page.

Supplied as one pre-filled pen, without other accessories.

Pen or vial?

PenVial
Form on arrivalSolution in a cartridge (dual-chamber: powder and solvent, mixed on activation)Lyophilised powder
ReconstitutionNot neededDone by the user with bacteriostatic water
MeasuringDial, fixed volume per clickSyringe, calculated per draw
Handling stepsOneSeveral
Price per mgHigherLower
Best forConvenience and repeatable volumesLowest cost and the longest unopened shelf life

Prefer the lyophilised vial? See GHK-CU 50mg.

Storage

Keep the pen refrigerated at 2–8 °C, in its box and away from light. Do not freeze. Do not use if the solution is cloudy, discoloured or contains particles. Short temperature excursions during shipping are expected and are covered by insulated packaging.

Quality and Certificate of Analysis

The substance in this pen comes from lot XD-CU50-PO06, tested by Liquilabs, an independent laboratory: >99.8% purity by HPLC, with identity confirmed and endotoxin and heavy metals tested on the same report. The report is published in our lab reports archive, and the lot number can be checked on the laboratory's own site. The certificate describes the lyophilised source lot; the finished solution in the pen has not been analysed separately.

Frequently asked questions

When will my pre-ordered GHK-Cu Pen 50 mg ship?

As soon as the first production run arrives. You receive tracking by email on the day it leaves.

Does the GHK-Cu Pen 50 mg need to stay cold?

Yes. Keep it at 2–8 °C. It ships in insulated packaging.

What does the Certificate of Analysis cover?

The lot of lyophilised substance the pen was filled from. The finished solution in the pen has not been analysed separately.

What is in the box?

One pre-filled pen. Needles and other accessories are not included at the moment.

Is it the same substance as the vial?

Yes. It is the same substance in a different format.

Batch test records

The substance in this pen comes from the lot below. The report describes the lyophilised source lot; the finished solution in the pen has not been analysed separately.

XD-CU50-PO06Current lot
Tested
September 19, 2026
Assay
Purity, Endotoxin, Heavy metals
Purity
>99.8%